Patients with IBD face elevated risk of psychiatric disorders

BETHESDA, MD (Aug. 4, 2026) — Patients with inflammatory bowel disease (IBD) face a significantly higher risk of psychiatric disorders starting two to three years before diagnosis and lasting up to a decade after, according to a nationwide study to be published in Clinical Gastroenterology and Hepatology. 

Researchers analyzed more than 40,000 Swedish IBD patients between 2007 and 2023, comparing them against nearly 180,000 general population and 26,000 IBD-free full siblings. Notably, mental health risks peaked shortly after diagnosis and remained elevated long-term. This held even when compared directly to patients’ IBD-free full siblings, indicating that shared family genetics or early environmental factors alone do not explain the link. 

IBD — which includes Crohn’s disease and ulcerative colitis — is a lifelong condition that causes chronic inflammation in the digestive tract. Because it affects daily physical comfort and social functioning, its impact extends beyond gut health. Scientists suspect the connection may involve protracted disease course, disrupted gut-brain axis communication, reduced social functioning, impaired quality of life, and shared genetic factors. 

“It is time to actively manage psychiatric conditions in patients with IBD,” said lead author Jiangwei Sun, PhD. 

Key takeaways: 

• Timeline of risk: Risk of psychiatric illness rises two–three years before IBD diagnosis, peaks within the first six months (a 50% increase), and stays elevated at 10 years (a 19% increase). 
• Main conditions: The risk increase was largely driven by major depressive disorder, anxiety disorders, and substance misuse. 
• Drug prescriptions: Prescriptions for antidepressants and anxiolytics increased a year before diagnosis and remained elevated for at least five years post-diagnosis. 
• Impact across subtypes: Results were consistent across Crohn’s disease, ulcerative colitis, and unclassified IBD, with absolute risks highest in patients with childhood-onset IBD and those with a family history of psychiatric conditions. 

While anxiety and depression are recognized as the most common mental health challenges in IBD patients, previous research focused almost exclusively on the years following diagnosis. By highlighting the critical, previously understudied years leading up to an IBD diagnosis, this new study shows how unaddressed mental health issues can complicate medical management, worsen flare-ups, and lower quality of life. Researchers urge health care providers to screen for psychiatric symptoms early — starting during the initial GI evaluation — and call for integrating psychological care directly into routine IBD management. 

AGA resources to support patients with IBD:

• AGA GI Patient Center 
• My IBD Life 
• IBD Drug Guide 

# # # 

AGA Media Contact: Annie Mehl, communications and media relations manager, media@gastro.org, 301-327-0013    

About the AGA Institute    
The American Gastroenterological Association is the trusted voice of the GI community. Founded in 1897, AGA represents members from around the globe who are involved in all aspects of the science, practice, and advancement of gastroenterology. The AGA Institute administers the practice, research, and educational programs of the organization. www.gastro.org    

About Clinical Gastroenterology and Hepatology  
The mission of Clinical Gastroenterology and Hepatology (CGH) is to provide readers with a broad spectrum of themes in clinical gastroenterology and hepatology, including the diagnostic, endoscopic, interventional, and therapeutic advances in cancer, inflammatory diseases, functional gastrointestinal disorders, nutrition, absorption, and secretion. More  

AGA is on Instagram.    
Like AGA on Facebook.    
Follow us on X @AmerGastroAssn and Bluesky @amergastroassn.bsky.social.    
Check out our videos on YouTube.    
Join AGA on LinkedIn.